A nanomaterial-based, cost-effective method for nucleic acid detection, crucial in identifying pathogens like COVID-19, has been developed to reduce testing costs.
Researchers have created a new version of a microbe to compete economically with E. coli to conduct low-cost and scalable synthetic biological experiments.
